Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
154 studies found for:    KL
Show Display Options
Rank Status Study
1 Completed Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: KL7016 900mg;   Drug: KL7016 600mg;   Drug: Placebo
2 Completed Clinical Image Evaluation for the DREX-KL80 Imaging System
Condition: Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation.
Intervention: Device: Radiography and Fluoroscopy Imaging System
3 Completed The Role of KL-6 in the Clinical Diagnosis of ILD
Condition: Interstitial Lung Disease
Intervention:
4 Terminated
Has Results
KL₄Surfactant Treatment in Patients With ARDS
Condition: Acute Respiratory Distress Syndrome
Interventions: Drug: Lucinactant;   Other: Standard of Care
5 Completed
Has Results
Impact of Volunteer Peer-Led Intervention for Weight Control in Primary Care
Condition: Weight Loss
Intervention: Behavioral: Weight loss Groups
6 Completed
Has Results
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
Condition: Acute Hypoxemic Respiratory Failure
Interventions: Drug: Lucinactant;   Other: Sham Comparator
7 Active, not recruiting Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease
Condition: Interstitial Lung Disease, Desquamative
Intervention:
8 Active, not recruiting Cognitive Dysfunction In Parkinson's
Condition: Parkinson's
Interventions: Device: rTMS;   Device: Sham TMS
9 Unknown  KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis
Condition: Acute Viral Bronchiolitis
Intervention:
10 Terminated
Has Results
Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
Condition: Respiratory Distress Syndrome
Intervention: Drug: Aerosolized lucinactant
11 Completed Clinical Study to Prove Safety in Use (Irritability and Sensitization in Genital Mucosa) of an Intimate Lubricating Gel
Condition: Female Dry Genital Mucosa
Intervention: Device: KL029 Intimate Lubricant Gel
12 Completed Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
Conditions: Skin Irritability;   Skin Sensitization
Intervention: Device: KL029 Intimate Lubricant Gel
13 Completed Clinical Study for Perceived Effectiveness Evaluation of Moisturizing Action of Intimate Use Product in Postmenopausal Women
Condition: Female Dry Genital Mucosa
Intervention: Device: KL029 Intimate Lubricant Gel
14 Terminated
Has Results
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Condition: Meconium Aspiration
Interventions: Drug: Lucinactant;   Other: Standard Care
15 Completed Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
Condition: Acute Heart Failure
Intervention:
16 Completed Vitamin D and Sexual Health
Condition: Bacterial Vaginosis
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol);   Dietary Supplement: Placebo
17 Active, not recruiting Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence
Conditions: Medication Adherence & Literacy to Predict Readmission;   Post-discharge Pharmacist Counseling to Prevent Readmissions
Intervention: Other: Post-discharge counseling on medication adherence & literacy
18 Active, not recruiting Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Condition: Adverse Drug Events
Interventions: Other: Pharmacist obtains admission medication history;   Other: Pharmacy technician obtains admission medication history
19 Completed Educational Intervention on Weight Management in Chinese-American Children
Condition: Overweight
Intervention: Behavioral: behavioral intervention
20 Completed
Has Results
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
Condition: Cystic Fibrosis
Interventions: Drug: Lucinactant first;   Drug: Placebo first

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.